Trials / Not Yet Recruiting
Not Yet RecruitingNCT07468500
Real World Adherence of PCSK9 Targeted Therapy
Real World Adherence of PCSK9 Targeted Therapy: A Retrospective Analysis of Japan Databases
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,600 (estimated)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Retrospective observational cohort study to compare medication adherence at 12 months between patients in Japan with dyslipidemia and/or hypercholesterolemia (familial and non-familial hypercholesterolemia) who newly initiate inclisiran versus those who newly initiate evolocumab.
Conditions
Timeline
- Start date
- 2026-03-30
- Primary completion
- 2026-07-30
- Completion
- 2026-07-30
- First posted
- 2026-03-12
- Last updated
- 2026-03-20
Source: ClinicalTrials.gov record NCT07468500. Inclusion in this directory is not an endorsement.